Iron Deficiency Anemia Market Size, Share & Forecast Report 2025-2032
The Global Iron Deficiency Anemia Market reached US$ 4.39 billion in 2024 and is expected to reach US$ 7.33 billion by 2032, growing at a CAGR of 6.8 % during the forecast period 2025-2032.
Iron Deficiency Anemia Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/iron-deficiency-anemia-market?sz
The Iron Deficiency Anemia market focuses on diagnostic and treatment solutions, including iron supplements, intravenous iron therapy, and dietary interventions. Driven by rising anemia prevalence, increasing awareness, and advancements in iron formulations, the market is expanding. However, challenges such as side effects of iron therapy, high treatment costs, and limited access to healthcare in some regions persist.
List of the Key Players in the Iron Deficiency Anemia Market:
Daiichi Sankyo, Inc., Covis Pharma GmbH., Akebia Therapeutics, Inc., PHARMACOSMOS A/S, AbbVie., Shield Therapeutics plc, GSK plc, Rockwell Medical, Inc., Kye Pharmaceuticals, Inc., and Cadila Pharmaceuticals among others.
Industry Development:
In October 2024, P&G Health India, in collaboration with the Federation of Obstetric and Gynaecological Societies of India (FOGSI), introduced the '12 Ka Naara' campaign to address the widespread issue of iron deficiency anemia (IDA) in India. This initiative is particularly crucial as data from the National Family Health Survey (NFHS-5) highlights a concerning reality-around 57% of Indian women suffer from anemia, often without realizing it until it reaches a severe stage.
Growth Forecast Projected:
The Global Iron Deficiency Anemia Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Research Process:
Both primary and secondary data sources have been used in the global Iron Deficiency Anemia Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/iron-deficiency-anemia-market
Segment Covered in the Iron Deficiency Anemia Market:
By Therapy Type: Oral Iron Therapy (Ferrous Sulfate, Ferrous Gluconate, Ferrous Fumarate, Polysaccharide Iron Complex), Parenteral Iron Therapy (Ferric Carboxymaltose, Ferumoxytol, Iron Sucrose, Iron Dextran), Red Blood Cell Transfusion, Others.
By Age Group: Adults, Pediatric, Geriatric.
By End-user: Hospitals, Specialty Clinics, Homecare Settings.
Regional Analysis for Iron Deficiency Anemia Market:
The regional analysis of the Iron Deficiency Anemia Market covers key regions including North America, Europe, Asia Pacific Middle East and Africa and South America. The North America with a focus on the U.S., Canada, and Mexico; Europe, highlighting major countries like the U.K., Germany, France, and Italy, along with other nations in the region; Asia-Pacific, covering India, China, Japan, South Korea, and Australia, among others; South America, with emphasis on Colombia, Brazil, and Argentina; and the Middle East & Africa, which includes Saudi Arabia, the U.A.E., South Africa, and other countries. This comprehensive regional breakdown helps identify unique market trends and growth opportunities specific to each area.
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Benefits of the Report:
➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Top-down and bottom-up approach for regional analysis
➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.
➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market
Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/iron-deficiency-anemia-market
Browse More Reports: https://www.datamintelligence.com/research-report/iron-deficiency-anemia-market
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian